Single dose of 2009 H1N1 vaccine immunogenic in adults
An Australian group has reported results of a clinical trial to determine the safety and immunogenicity of a 2009 pandemic H1N1 influenza virus vaccine. Twenty-one days after the first of…
An Australian group has reported results of a clinical trial to determine the safety and immunogenicity of a 2009 pandemic H1N1 influenza virus vaccine. Twenty-one days after the first of…
Hosts: Vincent Racaniello and Dickson Despommier Vincent and Dickson discuss the promising results of a phase III trial of a malaria vaccine in African children. [powerpress url=”http://traffic.libsyn.com/twip/TWiP031.mp3″] Click the arrow…
…and survived better than the unaltered lymphocytes, probably because they were at least partially resistant to HIV infection. This important clinical trial is only the beginning of a new approach…
…primates with Ebola virus, it is not known if it would work in humans. Answering that question requires a clinical trial, and the article explores why this phase was not…
…severe fatigue, post-exertional malaise, pain, cognitive and sleep problems that affects 0.1-0.2% of the population. A previous randomized, phase II trial of rituximab treatment showed clinical benefit in 20 of…
…the virus. The results of a phase 3 clinical trial indicated that immunization protected not only against primary infection, but also against severe disease. Dengvaxia was licensed based on data…